首页> 外国专利> The manner which the screening does the sample which possesses anti- virus activity vis-a-vis the virus which is infected to the living thing which possesses acquisition immunity feature making use of the living thing individual or that cultured cell which possesses only natural immunity feature, and the manner which evaluates the said anti- virus activity making use of the living thing individual or that cultured cell which possesses only natural immunity feature

The manner which the screening does the sample which possesses anti- virus activity vis-a-vis the virus which is infected to the living thing which possesses acquisition immunity feature making use of the living thing individual or that cultured cell which possesses only natural immunity feature, and the manner which evaluates the said anti- virus activity making use of the living thing individual or that cultured cell which possesses only natural immunity feature

机译：相对于被感染了具有获得性免疫特征的生物体的病毒，利用生物体个体或仅具有天然免疫性特征的培养细胞，对具有被病毒感染的病毒进行具有抗病毒活性的样品的筛选方式以及利用仅具有天然免疫特征的生物个体或培养细胞来评价所述抗病毒活性的方式

页面导航

摘要
著录项
相似文献

摘要

As for this inventor, the infection death by the nuclear polyhedrosis virus of the kaiko larva, being the person clinical, the result that it remedies by ganshikurobiru and hosukarunetsuto, bidarabin and ribabirin which are used as the saitomegarouirusu infection curative medicine was obtained. As for the knowledge which this inventor discovers, by the fact that the living thing individual or that cultured cell which possesses only the natural immunity feature of the kaiko larva and the like is utilized, the fact that it can do the screening of the sample which possesses anti- virus activity vis-a-vis the virus which is infected to the living thing which possesses the acquisition immunity feature of the person et. al and to evaluate the said anti- virus activity, has been shown.

机译：对于该发明人，临床上已取得了由凯科幼虫的核多角体病毒引起的感染死亡的临床结果，其结果是由ganshikurobiru和hosukarunetsuto，bidarabin和ribabirin作为saitomegarouirusu感染治疗药物而进行了补救。本发明人发现的知识，是利用了仅具有海藻幼虫等的天然免疫特性的生物个体或培养细胞这一事实来进行的。相对于被具有人的获得性免疫特征的生物感染的病毒具有抗病毒活性。已经显示了Aβ1和评估所述抗病毒活性。

著录项

公开/公告号JPWO2005116269A1

专利类型
公开/公告日2008-04-03

原文格式PDF
申请/专利权人株式会社ゲノム創薬研究所;
展开▼

申请/专利号JP20060513824
发明设计人関水和久;
展开▼

申请日2005-04-18
分类号C12Q1/02;
国家 JP
入库时间 2022-08-21 20:17:05

相似文献

专利
外文文献
中文文献